Antibacterielle Peptide

Patent europeic · EP2125871 · Stritgà

Inscripziun en il register

Numer da publicaziun
EP2125871
Numer da la dumonda
EP08701953
Gener
Patent europeic cun effect per la Svizra ed il Liechtenstein
Status
Stritgà
Scrittira da patent
Concedì
Annunzià
28-01-2008
Publitgà
02-12-2009
Concedì
28-01-2015
Stritgà
31-01-2020
Motiv
Taxa annuala betg pajada
Classas IPC
A61K 38/06 (2006.01)
A61K 38/07 (2006.01)
A61K 38/16 (2006.01)
Prioritad
GB 0702021 02.02.2007
US 899149 P 02.02.2007
Dumonda PCT
PCT/GB2008/000281 28.01.2008
Publicaziun PCT
WO2008/093058 07.08.2008
Lingua da l’annunzia
englais
Funtauna
Swissreg

Istorgia

Quai che l’Institut federal da la proprietad intellectuala ha publitgà davart quest titel, il pli nov l’emprim.

  1. 19-08-2020

    Stritgà, taxa betg pajada

    Published in Swissreg on 19.08.2020

  2. 07-03-2015

    Represchentant inscrit

    Representative
    MICHELI & CIE SA, 122, Rue de Genève, Case postale 61, 1226 Thônex

    Published in Swissreg on 07.03.2015

  3. 28-01-2015

    Concedì

    Published in Swissreg on 28.01.2015

Partidas

Possessur

NovaBiotics Limited

Novabiotics Limited

The Cruickshank Building, Craibstone Aberdeen AB21 9TR, GB

Represchentant

MICHELI & CIE SA

122, Rue de Genève Case postale 61, 1226 Thônex

Inventur

O'NEIL, Deborah

Craibstone Aberdeen AB21 9TR, GB

Il register numna mintga partida cun num ed adressa. In possessur u in represchentant vegn collià cun in’organisaziun, sch’exact ina unitad giuridica dal register da commerzi porta ses num; la via d’ina partida betg enconuschida uschia na vegn betg mussada qua.